HomeTagsSGX

SGX

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

Why Concord New Energy Slashed Its Staff By 30% Despite The Green Boom In FY2025

https://open.spotify.com/episode/1410f2bEfJOeMrsTN7h0o5?si=3d3bfdb638864161 Introduction The global transition to renewable energy is frequently marketed as an unstoppable economic juggernaut,...
SGX-LISTED COMPANIES

Shangri-La Asia’s New Secret Brand Is Changing Luxury Travel Forever – FY2025

https://open.spotify.com/episode/47qSjuUFLJE9weFQMF1MbL?si=7156e1bb681a4c90 5 Surprising Shifts Redefining the Future of Luxury at Shangri-La The global travel industry is...
SGX-LISTED COMPANIES

Yunnan Energy Swaps Commodities For Green Infrastructure In FY2025

https://open.spotify.com/episode/7CLJDXt0eVhh2zP7bTs9zK?si=a562cf64ec304022 Yunnan Energy’s Strategic Retreat to Higher Ground In corporate strategy, as in viticulture, the most...
SGX-LISTED COMPANIES

How Koh Brothers Engineered An $18.6 Million Turnaround In FY2025

https://open.spotify.com/episode/0MR3rCI8pluQ2MExvdb3st?si=84a1d2c0be0e4fca A Tale of Two Financial Years In the unforgiving arena of Singapore’s built environment, a...
SGX-LISTED COMPANIES

Comba Telecom Achieves A HK$600 Million Profit Swing In FY2025

https://open.spotify.com/episode/5q9jIeZrKpi8aHfr6lVUgK?si=e06d62b5c9cc4b32 The 5 Most Surprising Takeaways from Comba Telecom’s 2025 Transformation In the high-stakes world of...
SGX-LISTED COMPANIES

LionGlobal Singapore Physical Gold ETF IPO – The Future Of Gold?

https://open.spotify.com/episode/6kpKs0ZalIOAyg2mowQ4b0?si=ecb285900e944a09 The "Paper Gold" Illusion: 5 Surprising Realities of the LionGlobal Singapore Physical Gold Fund For...
SGX-LISTED COMPANIES

Why Coal Is Making A Comeback For Geo Energy Resources

https://open.spotify.com/episode/6Mnp5thfFyTRy5RzqkuK0V?si=8cc76ce3ca8e4ac5 Why the "Death of Coal" is Complicated: 5 Surprising Truths from Geo Energy’s Radical...
SGX-LISTED COMPANIES

How Prudential Is Rewriting The Insurance Playbook In Asia & Africa – FY2025

https://open.spotify.com/episode/179npbE3EyADJeHJGsLRUy?si=1d98b4cb974c4760 The Inflection Point How does a financial institution with a nearly 180-year heritage maintain double-digit...
SGX-LISTED COMPANIES

What Top Glove’s Q2 FY2026 Comeback Reveals About Their Future

https://open.spotify.com/episode/39mX7dQugKGGzv4pVT0qdZ?si=20a8d898ed414522 The 92% Profit Surge The global manufacturing landscape has been defined by extreme volatility, yet...
SGX-LISTED COMPANIES

Manulife US REIT FY2025 Survival Plan

https://open.spotify.com/episode/0Q7vFX5d2rhOFfaBUXy8dN?si=26dcc38470b84a9d How Manulife US REIT is Rebuilding for a Diversified Future Navigating the US Office Landscape The...
SGX-LISTED COMPANIES

How Renaissance United Is Trading Chinese Gas Woes For An AI-Fueled Tech Surge – Q3 2026

https://open.spotify.com/episode/3Untxmx3sSUqyGcUeOIJfC?si=a9f15312cb004ca7 Introduction In the volatile theater of global markets, the most significant shifts often occur at...
SGX-LISTED COMPANIES

Why China Medical Systems FY2025 Profits Dropped Despite Growth

https://open.spotify.com/episode/3YAldvdzS4eXE4RzkN9M18?si=8a54594510534cfe 5 Game-Changing Takeaways from CMS’s 2025 Transformation For the Chinese pharmaceutical sector, 2025 was the...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...